Avoro Capital Advisors LLC Q2 2020 Filing
Filed August 14, 2020
Portfolio Value
$5.1T
Holdings
44
Report Date
Q2 2020
Filing Type
13F-HR
All Holdings (44 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | —IMMUNOMEDICS INC | 26,250,000 | $930.3B | 18.39% | |
| 2 | MRTXEURMIRATI THERAPEUTICS INC | 4,286,765 | $489.4B | 9.68% | |
| 3 | HZNPHORIZON THERAPEUTICS PLC | 6,000,000 | $333.5B | 6.59% | |
| 4 | IOVAIOVANCE BIOTHERAPEUTICS INC | 10,361,039 | $284.4B | 5.62% | |
| 5 | SRPTSAREPTA THERAPEUTICS INC | 1,675,000 | $268.6B | 5.31% | |
| 6 | ASNDASCENDIS PHARMA | 1,750,000 | $258.8B | 5.12% | |
| 7 | BMRNBIOMARIN PHARMACEUTICAL INC | 1,850,000 | $228.2B | 4.51% | |
| 8 | ARGXARGENX SE | 970,000 | $218.5B | 4.32% | |
| 9 | —MYOKARDIA INC | 1,880,000 | $181.6B | 3.59% | |
| 10 | AM6AMICUS THERAPEUTICS INC | 11,000,000 | $165.9B | 3.28% | |
| 11 | ADVMCHFADVERUM BIOTECHNOLOGIES INC | 7,585,000 | $158.4B | 3.13% | |
| 12 | —MERSANA THERAPEUTICS INC | 6,500,000 | $152.1B | 3.01% | |
| 13 | KPTIEURKARYOPHARM THERAPEUTICS INC | 7,000,000 | $132.6B | 2.62% | |
| 14 | —CONSTELLATION PHARMACEUTICALS INC | 4,000,000 | $120.2B | 2.38% | |
| 15 | DCPHEURDECIPHERA PHARMACEUTICALS INC | 1,860,000 | $111.1B | 2.20% | |
| 16 | ADAPYADAPTIMMUNE THERAPEUTICS PLC | 10,200,000 | $100.2B | 1.98% | Call |
| 17 | XLRNACCELERON PHARMA INC | 1,040,000 | $99.1B | 1.96% | |
| 18 | QUREUNIQURE NV | 1,500,000 | $67.6B | 1.34% | |
| 19 | RLMDRELMADA THERAPEUTICS INC | 1,425,000 | $63.8B | 1.26% | |
| 20 | —ZOGENIX INC | 2,250,000 | $60.8B | 1.20% | |
| 21 | ARNAEURARENA PHARMACEUTICALS INC | 950,000 | $59.8B | 1.18% | |
| 22 | ATNXEURATHENEX INC | 3,850,000 | $53.0B | 1.05% | |
| 23 | ALLOALLOGENE THERAPEUTICS INC | 1,128,594 | $48.3B | 0.96% | |
| 24 | CUECUE BIOPHARMA INC | 1,870,000 | $45.8B | 0.91% | |
| 25 | MDGLMADRIGAL PHARMACEUTICALS INC | 350,000 | $39.6B | 0.78% | |
| 26 | TREURTRILLIUM THERAPEUTICS INC | 4,750,000 | $38.4B | 0.76% | |
| 27 | AVDLAVADEL PHARMACEUTICALS PLC | 4,565,655 | $36.9B | 0.73% | |
| 28 | OPHTEURIVERIC BIO INC | 7,100,000 | $36.2B | 0.72% | |
| 29 | XENEXENON PHARMACEUTICALS INC | 2,800,000 | $35.1B | 0.69% | |
| 30 | —MARINUS PHARMACEUTICALS INC | 11,960,000 | $30.4B | 0.60% | |
| 31 | AUPHAURINIA PHARMACEUTICALS INC | 1,670,000 | $27.1B | 0.54% | |
| 32 | BDTXBLACK DIAMOND THERAPEUTICS INC | 525,000 | $22.1B | 0.44% | |
| 33 | —RETROPHIN INC | 1,050,000 | $21.4B | 0.42% | |
| 34 | CBAYUSDCYMABAY THERAPEUTICS INC | 5,250,000 | $18.3B | 0.36% | |
| 35 | KURAKURA ONCOLOGY INC | 1,050,000 | $17.1B | 0.34% | |
| 36 | RNAAVIDITY BIOSCIENCES INC | 585,000 | $16.5B | 0.33% | |
| 37 | 1T7TRICIDA INC | 600,000 | $16.5B | 0.33% | |
| 38 | PTCTPTC THERAPEUTICS INC | 324,750 | $16.5B | 0.33% | |
| 39 | FRXFENNEC PHARMACEUTICALS INC | 1,670,000 | $13.9B | 0.28% | |
| 40 | AMRNAMARIN CORP PLC | 2,000,000 | $13.8B | 0.27% | |
| 41 | RVMDREVOLUTION MEDICINES INC | 304,000 | $9.6B | 0.19% | |
| 42 | —BIODELIVERY SCIENCES INTL | 2,034,900 | $8.9B | 0.18% | |
| 43 | CRDFCARDIFF ONCOLOGY INC | 1,000,000 | $5.0B | 0.10% | |
| 44 | —ALIMERA SCIENCES INC | 415,999 | $2.6B | 0.05% |